Total Payments
$352,707
2024 Payments
$93,216
Companies
30
Transactions
585
Medicare Patients
992
Medicare Billing
$109,062
Payment Breakdown by Category
Other$298,794 (84.7%)
Travel$32,993 (9.4%)
Food & Beverage$13,240 (3.8%)
Consulting$7,465 (2.1%)
Education$214.74 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $269,719 | 107 | 76.5% |
| Travel and Lodging | $32,993 | 77 | 9.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $29,075 | 14 | 8.2% |
| Food and Beverage | $13,240 | 378 | 3.8% |
| Consulting Fee | $7,465 | 6 | 2.1% |
| Education | $214.74 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $138,256 | 86 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $73,121 | 73 | $0 (2024) |
| Janssen Biotech, Inc. | $72,205 | 131 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $32,792 | 73 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $32,076 | 49 | $0 (2024) |
| Celgene Corporation | $1,637 | 20 | $0 (2024) |
| ABBVIE INC. | $642.36 | 24 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $389.66 | 34 | $0 (2017) |
| Allergan, Inc. | $209.14 | 15 | $0 (2020) |
| QOL Medical, LLC | $196.78 | 20 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93,216 | 87 | Janssen Biotech, Inc. ($55,275) |
| 2023 | $82,507 | 77 | E.R. Squibb & Sons, L.L.C. ($55,354) |
| 2022 | $82,887 | 81 | E.R. Squibb & Sons, L.L.C. ($33,875) |
| 2021 | $46,022 | 38 | E.R. Squibb & Sons, L.L.C. ($33,023) |
| 2020 | $9,283 | 59 | Janssen Scientific Affairs, LLC ($8,553) |
| 2019 | $36,708 | 92 | Janssen Scientific Affairs, LLC ($35,872) |
| 2018 | $1,038 | 72 | Janssen Biotech, Inc. ($367.83) |
| 2017 | $1,046 | 79 | Takeda Pharmaceuticals America, Inc. ($389.66) |
All Payment Transactions
585 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $653.23 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 12/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $653.23 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 12/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $653.23 | General |
| Category: Immunology | ||||||
| 11/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $823.98 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $690.88 | General |
| Category: Immunology | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Travel and Lodging | Cash or cash equivalent | $20.99 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | STELARA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $429.65 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $130.17 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $608.10 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $125.31 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $110.51 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 255 | 283 | $273,585 | $30,731 |
| 2022 | 7 | 294 | 324 | $341,587 | $34,119 |
| 2021 | 9 | 264 | 286 | $184,937 | $26,985 |
| 2020 | 8 | 179 | 213 | $125,850 | $17,227 |
Total Patients
992
Total Services
1,106
Medicare Billing
$109,062
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 103 | $28,222 | $11,228 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $16,068 | $5,463 | 34.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $56,738 | $5,421 | 9.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $87,290 | $3,167 | 3.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 32 | 35 | $77,280 | $2,798 | 3.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $7,672 | $2,479 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 21 | $315.00 | $176.40 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 90 | $24,632 | $9,916 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $23,034 | $7,950 | 34.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 34 | 34 | $87,686 | $7,250 | 8.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $112,230 | $3,589 | 3.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 37 | 39 | $86,112 | $2,894 | 3.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $7,398 | $2,422 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 33 | $495.00 | $97.59 | 19.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 64 | 64 | $26,152 | $9,412 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 59 | $15,566 | $6,720 | 43.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 18 | 18 | $39,090 | $3,519 | 9.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 31 | 34 | $56,107 | $2,752 | 4.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 19 | 19 | $38,212 | $1,674 | 4.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $3,866 | $1,383 | 35.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 12 | $2,364 | $768.79 | 32.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 20 | 24 | $2,805 | $628.04 | 22.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 39 | 43 | $775.00 | $129.00 | 16.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 56 | $14,000 | $4,911 | 35.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 39 | 39 | $15,600 | $4,815 | 30.9% |
About Dr. Martin Wolff, M.D
Dr. Martin Wolff, M.D is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1164666244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Wolff, M.D has received a total of $352,707 in payments from pharmaceutical and medical device companies, with $93,216 received in 2024. These payments were reported across 585 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($269,719).
As a Medicare-enrolled provider, Wolff has provided services to 992 Medicare beneficiaries, totaling 1,106 services with total Medicare billing of $109,062. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 04/21/2009
- Last Updated 05/23/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1164666244
Products in Payments
- ZEPOSIA (Drug) $138,693
- STELARA (Biological) $95,084
- TREMFYA (Drug) $50,078
- ENTYVIO (Biological) $32,446
- XIFAXAN (Drug) $22,127
- TRULANCE (Drug) $9,847
- Entyvio (Biological) $480.34
- RINVOQ (Biological) $327.97
- Sucraid (Drug) $196.78
- REMICADE (Biological) $150.25
- DIFICID (Drug) $145.12
- Amitiza (Drug) $144.94
- Humira (Biological) $132.23
- XELJANZ (Drug) $130.69
- VIBERZI (Drug) $117.86
- NASCOBAL (Drug) $113.45
- SKYRIZI (Biological) $112.00
- DUPIXENT (Biological) $110.97
- LINZESS (Drug) $106.90
- Linzess (Drug) $95.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Gastroenterology $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Gastroenterology $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Gastroenterology $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Gastroenterology $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Gastroenterology $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554
Gastroenterology $769,554